Simplex Trading’s MaxCyte MXCT Stock Holding History

Simplex Trading’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$702	Buy	+1,000	New	+$934	﹤0.01%	8676
2025 Q1	–	Sell	-500	Closed	-$2K	–	9243
2024 Q4	$2K	Hold	500	–	–	﹤0.01%	8042
2024 Q3	$1K	Sell	500 -400	-44%	-$1.69K	﹤0.01%	8220
2024 Q2	$3K	Buy	900 +500	+125%	+$2.15K	﹤0.01%	8131
2024 Q1	$1K	Sell	400 -1,500	-79%	-$7.04K	﹤0.01%	8602
2023 Q4	$8K	Buy	1,900 +1,100	+138%	+$4.28K	﹤0.01%	7594
2023 Q3	$2K	Sell	800 -300	-27%	-$1.21K	﹤0.01%	8129
2023 Q2	$5K	Buy	1,100 +200	+22%	+$919	﹤0.01%	7935
2023 Q1	$4K	Sell	900 -2,300	-72%	-$11.3K	﹤0.01%	8197
2022 Q4	$17K	Buy	+3,200	New	+$19.6K	﹤0.01%	7037

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

Simplex Trading's MXCT Position: Q1 2026 in Review

Simplex Trading opened a new position in MaxCyte (MXCT) in Q1 2026: 1,267 shares worth $890. The stake represents ﹤0.01% of the portfolio and ranks #8624 among its holdings. This is a return to the name: Simplex Trading previously reported a position in MXCT as recently as Q2 2025.

Simplex Trading first reported a position in MXCT in Q4 2022 and has held it in 9 quarters since. The position peaked at $13K in Q3 2024. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

Simplex Trading held 1,267 shares of MaxCyte worth $890 as of Q1 2026.
MaxCyte was a new Simplex Trading position in Q1 2026.
MaxCyte made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8624 holding.
Simplex Trading first reported a position in MaxCyte in Q4 2022 and has held it in 9 quarters since.
Simplex Trading's MaxCyte position peaked at $13K in Q3 2024.
130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.